IBRUTINIB-RITUXIMAB FOLLOWED BY REDUCED CHEMO-IMMUNOTHERAPY...

Hematological Oncology 2017 / 06 Vol. 35

IBRUTINIB-RITUXIMAB FOLLOWED BY REDUCED CHEMO-IMMUNOTHERAPY CONSOLIDATION IN YOUNG, NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS: a WINDOW OF OPPORTUNITY TO REDUCE CHEMO

Wang, M.L., Lee, H., Thirumurthi, S., Chuang, H., Hagemeister, F., Westin, J., Fayad, L., Samaniego, F., Turturro, F., Chen, W., Oriabure, O., Feng, L., Zhou, S., Huang, S., Li, S., Zhang, L., Badillo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_132
Date:
June, 2017
File:
PDF, 105 KB
english, 2017
Conversion to is in progress
Conversion to is failed